摘要
Dexosome是由树突状细胞分泌的膜小泡 ,同时表达MHC Ⅰ ,Ⅱ类分子及共刺激分子CD86 ,能够活化T细胞产生免疫应答 ,并可能参与T细胞介导的外周免疫耐受 ,其在抗肿瘤免疫疗法中的效用具有诱人的前景。
出处
《国外医学(生理病理科学与临床分册)》
2004年第1期22-25,共4页
Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
参考文献20
-
1Zitvogel L, Regnauh A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine : dendritic cell-derived exosomes[J]. Nat Med, 1998, 4(5) : 594-600.
-
2Bayes M, Rabasseda X, Prous JR. Gateways to Clinical Trials[ J ]. Methods Find Exp Clin Pharmacol, 2003, 25 ( 1 ) : 53-76.
-
3Clayton A, Harris CL, Court J, et al. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CIY59 [J]. Eur J Immunol, 2003, 33(2) : 522-531.
-
4Stahl PD, Barbieri MA. Muhivesicular bodies and muhivesicular endosomes: the "ins and outs" of endosomal traffic [J]. Sci Stke,2002, 2002( 141 ) :PE32.
-
5Savina A, Furlan M, Vidal M, et al. Exosome release is regulated by a calcium-dependent mechanism in K562 cells [ J ]. J Biol Chem, 2003, 278 (22) : 20083-20090.
-
6Thery C, Regnauh J, Garin J, et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73 [J]. J Cell Biol, 1999, 147(3) : 599-610.
-
7Thery C, Boussac M, Veron P, et al. Proteomic analysis of dendritic-cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles [ J ]. J Immunol, 2001, 166 (12) :7309 -7318.
-
8Wubbolts R, Leckie RS, Veenhuizen PT, et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation [J]. J Biol Chem, 2003, 278 (13):10963-10972.
-
9Babst M,Odorizzi G, Estepa EJ ,et al. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue,Vps23p,both function in late endosomal trafficking[J]. Traffic,2000,1 (3) :248-258.
-
10Farsad K. Exosomes: novel organelles implicated in immunomodulation mad aopotosis[J]. Yale J Biol Med, 2002, 75(2) : 95-101.
同被引文献28
-
1Spellberg B,Powers JH,Brass EP,et al.Trends in antimicrobial drug development:implications for the future[J].Clin Infect Dis,2004,38(9):1279-1286.
-
2Aoki H,Ke L,Poppe SM,et al.Oxazolidinone antibiotics target the P site on escherichia coli ribosomes[J].Antimicrob Agents Chemother,2002,46(4):1080-1085.
-
3Li Z,Willke RJ,Pinto LA,et al.Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin:a randomized,multicenter trial[J].Pharmacotherapy,2001,21 (3):263-274.
-
4Gonzales RD,Schreckenberger PC,Graham MB,et al.Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid[J].Lancet,2001,357(9263):1179.
-
5Nilius AM.Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class[J].Curr Opin Invest Drugs,2003,4(2):149-155.
-
6Barbachyn MR,Cleek GJ,Dolak LA,et al.Identification of phenylisoxazolines as novel and viable antibacterial agents active against gram-positive pathogens[J].J Med Chem,2003,46(2):284-302.
-
7Snyder,LB,Zheng Z.Novel isoxazolinone antibacterial agents[P].WO:0010566,2000-03-02.
-
8Wang D,Sutcliffe JA,Oyelere AK,et al.Bifunctional heterocyclic compounds and methods of making and using them[P].WO..2004029066,2004-04-08.
-
9Mohamed T,Das J,Natesan S,et al.Novel antiinfective compounds and their pharmaceutical compositions[P].WO:2004106329,2004-12-09.
-
10Chupak LS,Kaneko T,Josyula VP,et al.Oxazolidinone derivates N-substituted by a tricyclic ring,for use as antibacterial agents[P].WO:2004069245,2004-08-19.
二级引证文献5
-
1闫国婷,孙秀新,张宇婷.新型化学合成抗菌药物的研究进展[J].河北化工,2008(1):16-17. 被引量:2
-
2秦文灵,肖尚友,夏之宁.噁唑烷酮抗菌剂构效关系研究进展[J].中国药学杂志,2010,45(13):961-965. 被引量:2
-
3杨燕,尤启冬.噁唑烷酮类抗菌剂构效关系及结构改造研究进展[J].药学进展,2010,34(11):481-490. 被引量:5
-
4孙云萍,潘雯,宫建,顾敏华,黄晓艳,朴哲,吕丽娜,徐文明,冒小鸥,孙永发,陈建峰.沈阳市某二级甲等医院妇产科围手术期抗菌药物不良事件的调查分析[J].中华妇幼临床医学杂志(电子版),2013,9(5):536-539. 被引量:14
-
5赵胜贤,厉昆,胡红华,李啸风,任党培,金晓鲁,陈治.一种新型噁唑烷酮类抗生素的合成[J].合成化学,2017,25(3):265-269. 被引量:3
-
1舒翠玲.CD28受体分子的研究进展[J].细胞与分子免疫学杂志,1997,13(A02):8-11.
-
2周辛波.抗肿瘤药物—PD-1抑制剂[J].临床药物治疗杂志,2015,13(6):92-92. 被引量:11
-
3赵刚,苏庆,李静,刘爱芹.调节性T细胞的分子靶向作用与肿瘤免疫治疗[J].国际肿瘤学杂志,2013,40(6):409-412.
-
4王凌菲,王皓.受体酪氨酸激酶样孤儿受体在肿瘤免疫治疗中的研究进展[J].现代免疫学,2015,35(2):167-171. 被引量:3
-
5陈云,姚堃,孙华,彭光勇,丁传林,谢芳艺,周峰.含EB病毒LMP2A毕氏酵母表达载体的构建与表达LMP2A蛋白的检测[J].南京医科大学学报(自然科学版),2004,24(3):297-300. 被引量:1
-
6马培奇(译).抗肿瘤生物响应调节剂的研究进展[J].中国制药信息,2007,23(4):4-10.
-
7吴学忠,姚建婷,李中伟,赵天恩.HPV的细胞免疫应答研究进展[J].中国麻风皮肤病杂志,2007,23(10):884-887.
-
8项树林,肖瑶,李燕,朱秋屏,谷淑燕.Epstein-Barr病毒基因工程亚单位疫苗膜抗原gp340/220的纯化及其免疫学特性[J].中华实验和临床病毒学杂志,1996,10(4):344-348.
-
9曾小平,王红梅,黄永红,周晓燕,蔡震宇,徐方云.阿霉素联合致敏树突状细胞对荷宫颈癌小鼠的治疗作用[J].中国病理生理杂志,2013,29(4):734-738. 被引量:1
-
10陆英,陈炳官.骨髓来源的抑制性细胞的研究进展[J].国际免疫学杂志,2009,32(6):457-461. 被引量:2